Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

BTAI — BioXcel Therapeutics, Inc. Dilution Risk Tracker

Track BTAI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BTAI — Get alerts when the score changes →

As of October 13, 2026, BioXcel Therapeutics, Inc. (BTAI) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. BioXcel Therapeutics, Inc. has a market capitalization of $2.32M, 31.31M shares outstanding, 41 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $62.50M, 7.86M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
50
💰 Cash Runway
95
📊 Float Risk
30
⚠️ Warrant Exposure
70
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 58%
💰 Capital Raise model 73%
• Critical: only 1.6 months cash remaining
• Active ATM program with $62M remaining capacity
🔄 Reverse Split model est. 45%
• 50-day avg $1.20 approaching $1 threshold
• Only 2 months cash — financial pressure
📜 Warrant Exercise model 40%
• Significant warrants: 25% of shares outstanding
• Elevated warrant risk score (70/100)
🔔 Track BTAI — Get forecast alerts →

Market Data

Market Cap$2.32M
Shares Outstanding31.31M
Float26.40M
Cash$12.84M
Debt$104.45M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding31.31MVerified float table or market cache
Public Float26.40MVerified float table or market cache
Market Cap$2.32MMarket data cache
Cash Runway1.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$62.50MSEC-derived dilution fields
Outstanding Warrants7.86MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 4, 424B5 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 73.9% shares (2026Q1 vs prior)
41 institutional holders · 6.18M shares
#1 MILLENNIUM MANAGEMENT LLC 1.94M shares
#2 ARMISTICE CAPITAL, LLC 1.91M shares
#3 OAKTREE CAPITAL MANAGEMENT LP 723.6K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.12M
Days to Cover1.0
% of Float23.2%
FINRA data as of Aug 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
4 INSIDER TRANSACTION 2026-03-16
4 INSIDER TRANSACTION 2026-03-16
4 INSIDER TRANSACTION 2026-03-16
4 INSIDER TRANSACTION 2026-03-16
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BTAI Dilution Snapshot

BioXcel Therapeutics, Inc. (BTAI) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BTAI's DilutionScore is currently 65/100 (High risk), with 1 score change tracked over 89 days. The score deteriorated from 72/100 (High risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202665/100HIGH60 days
Jul 16 – Aug 13, 202672/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

BTAI shares outstanding have increased 41.2% from 21.87M (Mar 2026) to 30.88M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 202630.88M26.40M▲ 2.29%
May 23, 202630.88M25.81M▼ 8.16%
May 17, 202627.07M28.11M▲ 14.05%
May 09, 202627.07M24.64M▼ 0.11%
Apr 01, 202624.35M24.67M▲ 1.10%
Mar 31, 202624.35M24.40M▲ 23.80%
Mar 17, 202621.87M19.71M▼ 1.00%
Mar 14, 202621.87M19.91M▲ 2.28%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track BTAI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BTAI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BTAI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BTAI
BTAI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.